Work

A Phase III Randomized Intergroup Trial (SWOG S0016) of CHOP Chemotherapy Plus Rituximab Vs. CHOP Chemotherapy Plus Iodine-131-Tositumomab for the Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphoma

Year: 2011

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v118.21.98.98

Authors: Oliver W. Press, Joseph M Unger, Lisa M. Rimsza, Jonathan Friedberg, Michael LeBlanc, Myron S. Czuczman, Mark S. Kaminski, Rita M. Braziel, David G. Maloney, Bruce D. Cheson, Thomas P. Miller, Richard I Fisher

Institutions: Fred Hutch Cancer Center, SWOG Cancer Research Network, University of Arizona, University of Rochester Medicine, University of Rochester, Roswell Park Comprehensive Cancer Center, University of Michigan, Oregon Health & Science University, Georgetown University, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, University of Arizona Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979739655

FWCI: 2.804

Cites:

Cited by: 17

Related to: 10